HNRNPA2B1 and gastric cancer: TCF7L2 activates Wnt/β‐catenin signaling resulting in cetuximab resistance.[37] Multidrug resistance to vincristine, doxorubicin, and 5‐FU due to hnRNPA2B1 overexpression and Wnt/β‐catenin pathway activation occurs in gastric cancer cells.